Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ABPI President Steps Down Amid Novo Nordisk Code Of Practice Breach

Executive Summary

The president of the Association of the British Pharmaceutical Industry and UK head of Novo Nordisk, Pinder Sahota, has resigned from the role at the association after the company breached the ABPI Code of Practice. 

You may also be interested in...

Canadian HTA Ups Industry Fees To Fund Review Process Improvements

Canada’s health technology appraisal body is to increase its industry fees well beyond inflation for conducting reviews and scientific advice. It says it will also improve its drug reimbursement review process.

Saudi Regulator Becomes First Arab Member Of PIC/S

Saudi Arabia’s medicines agency says its membership of the international Pharmaceutical Inspection Co-operation Scheme will contribute to developing and raising inspectors' efficiency.

France Trials Quicker Route To Patients For Innovative Medicines

France is piloting a new approach that will allow innovative products to be accessed by patients before a reimbursement price has been agreed.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts